Comparison
18q Partial Monosomy Syndrome C0265472 vs 17 20 Lyase Deficiency Isolated C3277849
Clinical comparison between 18q Partial Monosomy Syndrome and 17 20 Lyase Deficiency Isolated for differential diagnosis and treatment planning.
18q Partial Monosomy Syndrome C0265472
A chromosomal disorder involving deletion of part of chromosome 18. Causes developmental delays, intellectual disability, and various physical features. Treatment focuses on managing specific symptoms.
17 20 Lyase Deficiency Isolated C3277849
A rare enzymatic disorder affecting sex hormone production. Impairs development of sexual characteristics in both males and females. Treatment involves hormone supplementation.
6 comparison axes
Onset
18q Partial Monosomy Syndrome C0265472
0-0
17 20 Lyase Deficiency Isolated C3277849
0-18
Onset patterns differ
Severity
18q Partial Monosomy Syndrome C0265472
severe
17 20 Lyase Deficiency Isolated C3277849
severe
Different severity levels
Chronic
18q Partial Monosomy Syndrome C0265472
Chronic
17 20 Lyase Deficiency Isolated C3277849
Chronic
Differing course
Communicable
18q Partial Monosomy Syndrome C0265472
No
17 20 Lyase Deficiency Isolated C3277849
No
Different transmission
Body System
18q Partial Monosomy Syndrome C0265472
congenital
17 20 Lyase Deficiency Isolated C3277849
endocrine
Same/different system
Category
18q Partial Monosomy Syndrome C0265472
genetic
17 20 Lyase Deficiency Isolated C3277849
endocrine
Different category
Bottom line
18q-partial-monosomy-syndrome-C0265472 and 17-20-lyase-deficiency-isolated-C3277849 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 18q Partial Monosomy Syndrome C0265472 | 17 20 Lyase Deficiency Isolated C3277849 | Discriminating power |
|---|---|---|---|
| Development | Developmental delay and intellectual disability are described. | Cognitive effects are not established in the supplied description. | High |
| Physical or sexual features | Variable congenital physical features may occur. | Sexual characteristic development may be impaired in both sexes. | High |
| Primary system | A chromosomal congenital disorder, not primarily an isolated hormone defect. | An endocrine disorder of sex-hormone production. | Moderate |
When to favor each condition
Choose 18q Partial Monosomy Syndrome C0265472 when
Congenital anomalies with developmental delay
A chromosomal deletion better fits multisystem congenital findings.
High
Confirmed partial deletion of chromosome 18
The chromosomal result supports this diagnosis after clinician review.
High
Counseling for a copy-number finding
The stated etiology is chromosomal rather than enzymatic.
Moderate
Choose 17 20 Lyase Deficiency Isolated C3277849 when
Impaired sexual development or pubertal concern
The source centers on deficient sex-hormone production.
High
Endocrine results suggest sex-steroid deficiency
Specialist interpretation may support an enzyme disorder.
Moderate
No chromosomal deletion but pathway evidence
This is a different endocrine category from 18q deletion.
Moderate
How key tests differ
| Test | 18q Partial Monosomy Syndrome C0265472 | 17 20 Lyase Deficiency Isolated C3277849 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | May show partial deletion of chromosome 18. | Does not by itself diagnose an enzyme defect. | A chromosomal abnormality requires laboratory and clinician confirmation. |
| Sex-hormone profile | No specific hormone pattern or cutoff is established here. | May indicate impaired sex-hormone production; cutoffs are not supplied. | An abnormal result is not itself a diagnosis. |
| Targeted genetic or enzyme assessment | Focuses on chromosomal copy number. | May assess the relevant steroid pathway when indicated. | Selection depends on phenotype and specialist judgment. |
Prognosis comparison
18q Partial Monosomy Syndrome C0265472
- Outcome
- Chronic congenital condition with variable, unquantified outcome.
- Factors
- Deletion extent, associated features, and developmental support.
17 20 Lyase Deficiency Isolated C3277849
- Outcome
- Chronic endocrine condition; outcome is not quantified here.
- Factors
- Degree and timing of sex-hormone deficiency and access to care.
Time frame: Lifelong, with childhood or adolescent manifestations possible.
Confirmed findings, individual features, and supportive services; mortality is not established.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Delay and intellectual disability are described. Not identified as the primary feature here. Support needs should be individualized. |
| Sexual development | Not the defining problem in the source. Impaired sexual characteristics may require endocrine care. Hormone supplementation is mentioned, but no dose is established. |
| Associated physical problems | Various physical features may occur. Mainly sex-hormone effects are described. The full complication range is not established. |
Patient education highlights
- HighDifferent causes
One condition is a chromosomal deletion; the other is a rare enzyme disorder affecting sex hormones.
- HighResults need interpretation
An abnormal test is not automatically a diagnosis and should be reviewed by a clinician.
- MediumCare is individualized
Management may address specific symptoms or use hormone supplementation; doses are not provided here.